×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CDNA – caredx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CDNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/24
04:05 pm
cdna
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
Low
Report
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
11/20
01:33 pm
cdna
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
11/20
06:01 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/10
08:00 am
cdna
CareDx to Participate in Upcoming Investor Conferences
Medium
Report
CareDx to Participate in Upcoming Investor Conferences
11/9
01:11 am
cdna
CareDx (NASDAQ:CDNA) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Medium
Report
CareDx (NASDAQ:CDNA) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
11/7
04:34 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/7
04:05 pm
cdna
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
08:10 am
cdna
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
CareDx (NASDAQ:CDNA) had its price target raised by analysts at BTIG Research from $22.00 to $25.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
04:40 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Medium
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/14
11:21 am
cdna
Form SCHEDULE 13G CareDx, Inc. Filed by: BAMCO INC /NY/
Low
Report
Form SCHEDULE 13G CareDx, Inc. Filed by: BAMCO INC /NY/
11/10
04:15 pm
cdna
Form 4 CareDx, Inc. For: Nov 07 Filed by: Novack Jeffrey Adam
Low
Report
Form 4 CareDx, Inc. For: Nov 07 Filed by: Novack Jeffrey Adam
11/7
05:23 pm
cdna
Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam
Medium
Report
Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam
11/7
04:38 pm
cdna
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
Medium
Report
Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam
11/5
04:21 pm
cdna
Form 144 CareDx, Inc. Filed by: Jain Abhishek
Medium
Report
Form 144 CareDx, Inc. Filed by: Jain Abhishek
11/4
04:13 pm
cdna
Form 10-Q CareDx, Inc. For: Sep 30
High
Report
Form 10-Q CareDx, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
17.3%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
4/6 CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) 15.5%
5/8 Q1/2019 3/31/2019 EPS 0.050 ZacksConsensus -0.150 ActVsEst 0.200 - Beat 12.9%
1/13 Form 8-K CareDx, Inc. For: Jan 13 10.3%
4/14 CareDx Introduces AlloCell: Cell Therapy Surveillance 7.6%
9/11 CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7.4%
10/2 Form 4 CareDx, Inc. For: Oct 01 Filed by: COURNOYER CHRISTINE 7.4%
5/1 CareDx Inc (NASDAQ: CDNA) had its price target lowered by analysts at Piper Sandler from $59.00 to $54.00. They now have an "overweight" rating on the stock. 7.4%
3/20 New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy 7.0%
6/11 CareDx Inc (NASDAQ: CDNA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 6.6%
TOP News Decliners
3/16
Form 4 CareDx, Inc. For: Mar 16 Filed by: Maag Peter
-19.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
7/15 Form 4/A CareDx, Inc. For: Jun 17 Filed by: Goldberg Michael -12.9%
8/3 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against CareDx, Inc. -12.4%
10/31 Form 8-K CareDx, Inc. For: Oct 31 -12.0%
11/4 CareDx Advances Patient Care with AlloSure 3.0 -10.7%
3/12 CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community -10.2%
6/21 Form 4 CareDx, Inc. For: Jun 20 Filed by: Bell Michael Brian -10.0%
8/8 Form 4 CareDx, Inc. For: Aug 06 Filed by: Seeto Reginald -9.0%
7/16 Glancy Prongay & Murray LLP Announces Investigation on Behalf of CareDx, Inc. Investors (CDNA) -8.4%
10/16 CareDx Inc (NASDAQ: CDNA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -8.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: